Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

doi:10.1016/S1474-4422(17)30408-8

Paper

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

Published Jan 31, 2018 · Katrin Augustin, A. Khabbush, Sophie Williams

The Lancet Neurology

Q1 SJR score

291

Citations

10

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

The medium-chain triglyceride ketogenic diet may block seizure onset and raise seizure threshold by inhibiting AMPA receptors and changing cell energetics through mitochondrial biogenesis.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

Sign up to use Study Snapshot

References

Citations